Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mayumi Nakagawa

Concepts (235)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
15
2024
172
4.450
 Why?
Human papillomavirus 16
11
2021
44
3.510
 Why?
Uterine Cervical Neoplasms
10
2024
299
3.240
 Why?
Papillomavirus Vaccines
7
2021
69
3.190
 Why?
Oncogene Proteins, Viral
11
2011
54
2.390
 Why?
Papillomaviridae
7
2019
105
2.260
 Why?
Repressor Proteins
9
2011
154
2.050
 Why?
Epitopes, T-Lymphocyte
7
2018
26
1.850
 Why?
Cancer Vaccines
3
2021
78
1.560
 Why?
T-Lymphocytes
6
2021
329
1.390
 Why?
Candida
4
2018
63
1.300
 Why?
CD8-Positive T-Lymphocytes
6
2018
132
1.270
 Why?
Cervix Uteri
3
2021
49
0.860
 Why?
Uterine Cervical Dysplasia
2
2015
51
0.810
 Why?
Immunity, Cellular
4
2013
64
0.710
 Why?
Lymphocytes, Tumor-Infiltrating
1
2021
78
0.700
 Why?
Epitopes
2
2015
62
0.680
 Why?
Langerhans Cells
3
2018
11
0.680
 Why?
Neoplasms
2
2021
1308
0.650
 Why?
Viral Load
2
2019
80
0.640
 Why?
Health Education
1
2021
156
0.630
 Why?
Cell Cycle Checkpoints
1
2019
32
0.620
 Why?
HLA Antigens
4
2006
56
0.600
 Why?
Humans
43
2025
52593
0.570
 Why?
Adult
21
2025
14170
0.560
 Why?
CD4-Positive T-Lymphocytes
3
2018
165
0.550
 Why?
Colorectal Neoplasms
1
2021
295
0.550
 Why?
Female
29
2025
28262
0.540
 Why?
Health Knowledge, Attitudes, Practice
1
2021
510
0.520
 Why?
Plasma Exchange
2
2014
25
0.500
 Why?
Cross Protection
1
2015
4
0.480
 Why?
T-Lymphocytes, Regulatory
2
2016
84
0.480
 Why?
Colposcopy
1
2015
17
0.460
 Why?
Interleukin-12
2
2018
27
0.460
 Why?
Adjuvants, Immunologic
2
2018
52
0.450
 Why?
Immunity, Innate
1
2015
117
0.440
 Why?
Interferon-gamma
2
2012
179
0.430
 Why?
Health
1
2013
21
0.430
 Why?
Lectins, C-Type
1
2013
31
0.430
 Why?
Papillomavirus E7 Proteins
8
2018
32
0.420
 Why?
Middle Aged
15
2025
13096
0.420
 Why?
Young Adult
9
2021
4337
0.410
 Why?
Patient Selection
1
2015
266
0.410
 Why?
Afibrinogenemia
1
2012
5
0.390
 Why?
Enzyme-Linked Immunospot Assay
1
2012
3
0.380
 Why?
T-Lymphocytes, Cytotoxic
4
2009
65
0.380
 Why?
Breast Neoplasms
1
2021
1205
0.380
 Why?
Cell Proliferation
5
2021
1029
0.360
 Why?
Vaginal Smears
3
2021
28
0.360
 Why?
Warts
1
2010
13
0.350
 Why?
Plateletpheresis
1
2010
7
0.350
 Why?
Early Detection of Cancer
3
2021
183
0.350
 Why?
Antigens, Fungal
1
2010
20
0.340
 Why?
Blood Preservation
1
2010
27
0.340
 Why?
Dermatitis
1
2010
36
0.340
 Why?
Blood Proteins
1
2010
84
0.330
 Why?
Anaphylaxis
1
2010
69
0.330
 Why?
Cells, Cultured
5
2021
1588
0.310
 Why?
Antigens, Viral
2
2009
43
0.300
 Why?
Immunotherapy
1
2010
244
0.300
 Why?
Telemedicine
1
2015
493
0.290
 Why?
Human papillomavirus 18
1
2008
9
0.290
 Why?
Blood Platelets
1
2010
263
0.290
 Why?
Host-Pathogen Interactions
2
2021
144
0.280
 Why?
Vaccinia virus
1
2007
6
0.270
 Why?
Dendritic Cells
1
2008
136
0.270
 Why?
Hematopoietic Stem Cell Transplantation
2
2025
606
0.270
 Why?
Immunoenzyme Techniques
1
2007
136
0.260
 Why?
Immunophenotyping
1
2007
117
0.260
 Why?
Neoplasm Staging
2
2025
768
0.260
 Why?
Aged
10
2025
10191
0.240
 Why?
Blood Component Removal
1
2025
17
0.240
 Why?
Cell Line, Tumor
5
2021
1436
0.230
 Why?
Isoantibodies
1
2004
30
0.230
 Why?
Neoplasm Grading
2
2021
126
0.220
 Why?
Lead
1
2004
33
0.220
 Why?
Infant, Very Low Birth Weight
1
2004
55
0.220
 Why?
Neutropenia
1
2004
115
0.220
 Why?
Endometrial Neoplasms
1
2025
144
0.220
 Why?
Oropharyngeal Neoplasms
1
2024
19
0.210
 Why?
DNA, Viral
3
2011
138
0.210
 Why?
Anus Neoplasms
1
2024
25
0.210
 Why?
Hematopoietic Stem Cells
1
2025
188
0.210
 Why?
Blood Transfusion
1
2004
129
0.210
 Why?
Coinfection
1
2024
44
0.210
 Why?
Penile Neoplasms
1
2024
44
0.210
 Why?
High-Throughput Nucleotide Sequencing
2
2021
179
0.200
 Why?
Adolescent
5
2021
6737
0.200
 Why?
Antibody Formation
1
2002
51
0.190
 Why?
Capsid Proteins
1
2002
24
0.190
 Why?
Practice Guidelines as Topic
1
2025
496
0.190
 Why?
Genes, T-Cell Receptor
1
2021
5
0.190
 Why?
Clone Cells
3
2007
76
0.190
 Why?
Clinical Trials, Phase I as Topic
1
2021
24
0.180
 Why?
Cytokines
2
2016
626
0.180
 Why?
Treatment Outcome
3
2021
5486
0.180
 Why?
Pilot Projects
2
2021
721
0.180
 Why?
Remission Induction
1
2021
219
0.180
 Why?
Mass Screening
2
2021
358
0.180
 Why?
Lymphocyte Activation
1
2021
163
0.180
 Why?
Cystadenocarcinoma, Serous
1
2021
73
0.180
 Why?
Videotape Recording
1
2021
27
0.180
 Why?
Left-Right Determination Factors
1
2020
1
0.180
 Why?
Nodal Protein
1
2020
3
0.180
 Why?
Amino Acid Sequence
3
2008
574
0.170
 Why?
Mammography
1
2021
97
0.170
 Why?
Focus Groups
1
2021
197
0.160
 Why?
Enzyme-Linked Immunosorbent Assay
3
2010
237
0.160
 Why?
Multiple Myeloma
2
2025
3050
0.160
 Why?
Metagenome
1
2019
39
0.160
 Why?
Male
10
2024
26863
0.160
 Why?
Dose-Response Relationship, Drug
2
2016
1378
0.150
 Why?
Glioblastoma
1
2020
97
0.150
 Why?
Feasibility Studies
1
2021
403
0.150
 Why?
Parenteral Nutrition
1
2019
28
0.150
 Why?
Up-Regulation
1
2020
462
0.150
 Why?
Health Behavior
1
2021
257
0.150
 Why?
Transplantation Conditioning
1
2019
93
0.150
 Why?
DNA
1
2021
549
0.140
 Why?
Time Factors
2
2021
3000
0.140
 Why?
Bacteria
1
2019
220
0.140
 Why?
Leukocytes, Mononuclear
2
2016
122
0.140
 Why?
HLA-B Antigens
2
2008
8
0.140
 Why?
Age Factors
1
2021
1132
0.140
 Why?
Cell Line
2
2012
1033
0.140
 Why?
Ovarian Neoplasms
1
2021
460
0.130
 Why?
Brain Neoplasms
1
2020
290
0.130
 Why?
Histocompatibility Antigens Class II
2
2008
34
0.130
 Why?
Retrospective Studies
5
2025
6671
0.130
 Why?
Vaccines, Subunit
1
2016
15
0.130
 Why?
Head and Neck Neoplasms
1
2019
287
0.130
 Why?
Body Mass Index
1
2019
692
0.120
 Why?
Molecular Sequence Data
2
2008
773
0.120
 Why?
Adaptive Immunity
1
2015
33
0.120
 Why?
Chromatography, Liquid
1
2016
240
0.110
 Why?
Leukocyte Count
2
2004
73
0.110
 Why?
Peptides
2
2006
236
0.110
 Why?
Tandem Mass Spectrometry
1
2016
250
0.110
 Why?
Factor VIII
1
2014
23
0.110
 Why?
ADAM Proteins
1
2014
21
0.110
 Why?
Purpura, Thrombotic Thrombocytopenic
1
2014
15
0.110
 Why?
Proteome
1
2016
170
0.110
 Why?
Antigens, CD1
1
2013
9
0.110
 Why?
Mannose-Binding Lectins
1
2013
8
0.110
 Why?
Receptors, Pattern Recognition
1
2013
4
0.110
 Why?
Indicators and Reagents
1
2013
36
0.110
 Why?
Intracellular Space
1
2013
25
0.110
 Why?
Skin Tests
1
2013
58
0.110
 Why?
Vaccination
1
2016
299
0.110
 Why?
Cadherins
1
2013
63
0.100
 Why?
Proteomics
1
2016
327
0.100
 Why?
Communication
1
2015
257
0.100
 Why?
Rural Health Services
1
2015
169
0.100
 Why?
Research Design
1
2015
358
0.100
 Why?
Antigens, CD
1
2013
216
0.100
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
582
0.100
 Why?
Socioeconomic Factors
1
2015
606
0.100
 Why?
Longitudinal Studies
2
2005
747
0.090
 Why?
Injections, Intralesional
1
2010
31
0.090
 Why?
Isotonic Solutions
1
2010
20
0.090
 Why?
Platelet Transfusion
1
2010
33
0.090
 Why?
P-Selectin
1
2010
28
0.090
 Why?
Sodium Chloride
1
2010
56
0.080
 Why?
Platelet Aggregation
1
2010
78
0.080
 Why?
Platelet Activation
1
2010
49
0.080
 Why?
Hypersensitivity
1
2010
81
0.080
 Why?
Japan
2
2025
38
0.080
 Why?
Complement Factor I
1
2008
2
0.080
 Why?
Polymerase Chain Reaction
1
2010
460
0.080
 Why?
HLA-A Antigens
1
2008
11
0.070
 Why?
Haplotypes
1
2008
94
0.070
 Why?
Antigen Presentation
1
2008
26
0.070
 Why?
Immunologic Memory
1
2008
32
0.070
 Why?
Histocompatibility Antigens Class I
1
2008
48
0.070
 Why?
Prognosis
2
2025
2118
0.070
 Why?
Signal Transduction
2
2020
1714
0.070
 Why?
DNA, Recombinant
1
2007
15
0.070
 Why?
Animals
2
2019
13507
0.070
 Why?
Genes, MHC Class I
1
2006
11
0.070
 Why?
Arkansas
1
2013
2029
0.070
 Why?
Binding, Competitive
1
2006
90
0.070
 Why?
Polymorphism, Single Nucleotide
1
2008
506
0.060
 Why?
Leukapheresis
1
2025
19
0.060
 Why?
Antigens, CD34
1
2025
73
0.060
 Why?
Calgranulin B
1
2005
4
0.060
 Why?
Calgranulin A
1
2005
5
0.060
 Why?
Cryopreservation
1
2025
41
0.060
 Why?
Epitope Mapping
1
2004
6
0.060
 Why?
Immunomagnetic Separation
1
2004
8
0.060
 Why?
Societies, Medical
1
2025
202
0.050
 Why?
Risk Factors
1
2013
3952
0.050
 Why?
Transplantation, Autologous
1
2025
488
0.050
 Why?
Phosphorylation
2
2020
530
0.050
 Why?
Sensitivity and Specificity
1
2005
883
0.050
 Why?
Mutation
1
2008
1344
0.050
 Why?
Tumor Virus Infections
1
2002
48
0.050
 Why?
Antibodies, Viral
1
2002
110
0.050
 Why?
Lactobacillus
1
2021
4
0.050
 Why?
Immunoglobulin G
1
2002
195
0.050
 Why?
SOX Transcription Factors
1
2021
4
0.050
 Why?
Neuroendocrine Cells
1
2021
10
0.050
 Why?
Biological Specimen Banks
1
2021
22
0.050
 Why?
Cytodiagnosis
1
2021
43
0.050
 Why?
Neoplasm Recurrence, Local
1
2025
643
0.040
 Why?
Cytoplasm
1
2021
93
0.040
 Why?
Cobalt
1
2020
17
0.040
 Why?
Neoplastic Stem Cells
1
2021
93
0.040
 Why?
Recurrence
1
2002
683
0.040
 Why?
Cell Hypoxia
1
2020
83
0.040
 Why?
Vulnerable Populations
1
2020
52
0.040
 Why?
Cohort Studies
1
2004
1553
0.040
 Why?
Epithelial-Mesenchymal Transition
1
2020
58
0.040
 Why?
Community Health Workers
1
2020
50
0.040
 Why?
Cell Movement
1
2021
276
0.040
 Why?
Multivariate Analysis
1
2021
602
0.040
 Why?
Parenteral Nutrition, Total
1
2019
29
0.040
 Why?
Cell Survival
1
2020
602
0.040
 Why?
Sequence Analysis, DNA
1
2019
230
0.040
 Why?
Cell Differentiation
1
2021
673
0.040
 Why?
Phenotype
1
2021
800
0.040
 Why?
Linear Models
1
2019
292
0.040
 Why?
Models, Biological
1
2021
741
0.040
 Why?
Immunity, Humoral
1
2018
23
0.040
 Why?
Aged, 80 and over
1
2025
3420
0.030
 Why?
Infant, Newborn
1
2004
2891
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2020
857
0.030
 Why?
Autoantibodies
1
2014
121
0.030
 Why?
Immunosuppressive Agents
1
2014
250
0.020
 Why?
Mice, Inbred C57BL
1
2018
1900
0.020
 Why?
Combined Modality Therapy
1
2014
639
0.020
 Why?
Genetics, Population
1
2008
13
0.020
 Why?
Alleles
1
2008
278
0.020
 Why?
Mice
1
2018
5958
0.020
 Why?
Casein Kinase II
1
2005
10
0.010
 Why?
Cell Division
1
2005
288
0.010
 Why?
Nakagawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (235) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (37) people
_
Same Department Expand Description
Search Department